spacer
home > ict > autumn 2017 > teaming up
PUBLICATIONS
International Clinical Trials

Teaming Up

ICT: Your event claims it will provide discussions
regarding partnerships. What do these entail?


Louisa Maitland: Partnerships in Clinical Trials (PCT)
brings together groups of experts who are involved in
setting up, running and delivering trials; it is a meeting
place to discuss strategy, business and innovation.
Historically, PCT has mainly centred on the relationship
between the pharmaceutical or biotechnology company
and the CRO, but as the event has evolved over the
years, the focus has shifted. Today, a true partnership
will involve successful collaborations between sponsors,
CROs, regulators, investigators and, most importantly, the
patient. Communication and understanding of business
necessities are needed between all relevant parties, as
well as increasing operational efficiencies, streamlining
the development process, expanding global reach and
complementing internal knowledge with external expertise.

Throughout the industry, pharma and biotech
manufacturers, patient groups and policy makers are
continuing the mission to enhance collaborations with
subjects to align stakeholder needs and

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Louisa Maitland is Conference Director of PCT Europe, developing the event in partnership with the advisory board.
She completed an MSc at Kings College, UK, in forensic science and a BSc at Reading University, UK, in environmental science. After experience as both a Forensic Toxicologist and a Biochemist, for the last 16 years Louisa has worked in conference production, researching key trends and current challenges within various industry sectors, such as pharma, biotech and, most recently, clinical trials.
spacer
Louisa Maitland
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

New NoriZite™ Nasal Spray launches in the UK

Birmingham, UK,  28th October 2022 / Sciad Newswire / Birmingham Biotech LTD, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces that NoriZite™ Nasal Spray, an easy-to-use nasal device designed to block and trap inhaled virus particles, is now available to buy in the UK.
More info >>

White Papers

Considerations for Choosing the Right Wearable Drug Delivery System

West Pharmaceutical Services, Inc.

For patients with chronic conditions, the use of injectable biologic therapies is on the rise. Biologics, while providing considerable therapeutic benefit, can also present several challenges for both drug manufacturers and patients. In particular, many biologics are highly viscous and others require large doses to be injected slowly over time. This can make it difficult to deliver a consistent dose every time, potentially impacting medication adherence.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement